MSD Manual

Please confirm that you are a health care professional

Loading

Hematopoietic Cell Transplantation

By

Robert Peter Gale

, MD, PhD, Imperial College London

Last full review/revision Sep 2020| Content last modified Sep 2020
Click here for Patient Education

Hematopoietic cell transplants using cells from bone marrow, blood, or less often, umbilical cord blood cells are given after high- or moderate-dose chemotherapy and/or radiation therapy. Donors can be the person with cancer (an autotransplant) or an HLA-matched related or unrelated person (an allotransplant—see also Overview of Cancer Therapy). Typically, such transplants are reserved for patients with a high risk that conventional therapies will fail or in whom initial therapy has failed.

Autotransplants are used to treat lymphomas, multiple myeloma, and rare solid cancers such as testis cancer, Wilms and Ewing sarcomas, and neuroblastomas. Very occasionally, they are used to treat leukemias.

Allotransplants are used to treat leukemias and some lymphomas.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Hemochromatosis
Video
Overview of Hemochromatosis
Bone Marrow Biopsy
Video
Bone Marrow Biopsy

SOCIAL MEDIA

iOS Android
iOS Android
iOS Android
TOP